[go: up one dir, main page]

PA8548301A1 - Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion - Google Patents

Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion

Info

Publication number
PA8548301A1
PA8548301A1 PA20028548301A PA8548301A PA8548301A1 PA 8548301 A1 PA8548301 A1 PA 8548301A1 PA 20028548301 A PA20028548301 A PA 20028548301A PA 8548301 A PA8548301 A PA 8548301A PA 8548301 A1 PA8548301 A1 PA 8548301A1
Authority
PA
Panama
Prior art keywords
procedure
preparation
pharmaceutical formulation
flavor
masked flavor
Prior art date
Application number
PA20028548301A
Other languages
English (en)
Inventor
Philippe Becourt
Josiane Chauvin
Detlev Schwabe
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PA8548301A1 publication Critical patent/PA8548301A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A UNA FORMULACION FARMACEUTICA EN FORMA DE POLVO, DESTINADA A SER ADMINISTRADA EN SUSPENCION ACUOSA POR VIA ORAL, QUE TIENE EL SABOR ENMASCARADO, QUE INCLUYE POR LO MENOS UN POLIMERO CELULOSICO, UN POLIMERO METACRILICO Y UN PRINCIPIO ACTIVO DISTRIBUIDO DE MANERA HOMOGENEA Y EN ESTADO MOLECULAR EN UNA MATRIZ ATOMIZADA, ASI COMO UN AGENTE ALCALINO Y UN AGENTE ADSORBENTE, AL PROCEDIMIENTO PARA SU PREPARACION, ASI COMO A UN METODO DE ENMASCARAMIENTO DEL SABOR DE PRODUCTOS FARMACEUTICOS.
PA20028548301A 2001-06-21 2002-06-19 Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion PA8548301A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0108157A FR2826274B1 (fr) 2001-06-21 2001-06-21 Formulation pharmaceutique au gout masque et son procede de preparation

Publications (1)

Publication Number Publication Date
PA8548301A1 true PA8548301A1 (es) 2003-09-05

Family

ID=8864587

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20028548301A PA8548301A1 (es) 2001-06-21 2002-06-19 Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion

Country Status (41)

Country Link
US (2) US7138138B2 (es)
EP (1) EP1401397B1 (es)
JP (1) JP4880871B2 (es)
CN (1) CN1239149C (es)
AP (1) AP1595A (es)
AR (1) AR036096A1 (es)
AT (1) ATE290366T1 (es)
AU (1) AU2002329311B2 (es)
BG (1) BG66314B1 (es)
BR (1) BRPI0208998A2 (es)
CA (1) CA2452239C (es)
CO (1) CO5540278A2 (es)
CZ (1) CZ299947B6 (es)
DE (1) DE60203178T2 (es)
EA (1) EA006016B1 (es)
EC (1) ECSP034915A (es)
ES (1) ES2236574T3 (es)
FR (1) FR2826274B1 (es)
GT (2) GT200200115A (es)
HR (1) HRP20031067B1 (es)
HU (1) HUP0400799A3 (es)
IL (2) IL159404A0 (es)
JO (1) JO2325B1 (es)
MA (1) MA27042A1 (es)
MX (1) MXPA03011756A (es)
MY (1) MY134340A (es)
NO (1) NO332258B1 (es)
NZ (1) NZ530042A (es)
OA (1) OA12635A (es)
PA (1) PA8548301A1 (es)
PE (1) PE20030201A1 (es)
PL (1) PL202090B1 (es)
PT (1) PT1401397E (es)
SK (1) SK285865B6 (es)
SV (1) SV2003001098A (es)
TN (1) TNSN03141A1 (es)
TW (1) TWI228049B (es)
UA (1) UA77960C2 (es)
UY (1) UY27341A1 (es)
WO (1) WO2003000225A2 (es)
ZA (1) ZA200309479B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
GB2419094A (en) * 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
FR2882522B1 (fr) 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
KR101387249B1 (ko) * 2006-02-03 2014-05-21 에보니크 룀 게엠베하 물에 난용성인 유효 성분과 중합체의 혼합물을 함유하는제약 조성물
WO2007108010A2 (en) * 2006-03-21 2007-09-27 Jubilant Organosys Limited Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
KR100935893B1 (ko) * 2007-09-11 2010-01-07 국방과학연구소 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법
US9453042B2 (en) 2007-10-25 2016-09-27 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
DK2379635T3 (en) 2008-12-16 2016-12-05 Carlsberg As Cellulosic polymer material
IN2014DN08939A (es) 2012-03-27 2015-05-22 Cempra Pharmaceuticals Inc
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
RU2017104163A (ru) * 2014-08-05 2018-09-06 Семпра Фармасьютикалз, Инк. Порошкообразные составы пероральных суспензий антибактериальных агентов
US10982177B2 (en) 2017-09-18 2021-04-20 The Clorox Company Cleaning wipes with particular lotion retention and efficacy characteristics
CN114209661B (zh) * 2022-02-21 2022-04-29 北京罗诺强施医药技术研发中心有限公司 呈细粒形式的固体药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930409A1 (de) * 1979-07-26 1981-02-12 Bayer Ag Spruehtrocknung von mikrokapseldispersionen
JPS63150220A (ja) * 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
JP2001518490A (ja) * 1997-10-03 2001-10-16 エラン コーポレーシヨン ピーエルシー 味遮蔽された製剤
IN191239B (es) * 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
US6555569B2 (en) * 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
ES2313975T3 (es) * 2000-08-22 2009-03-16 Basilea Pharmaceutica Ag Nuevos macrolidos con actividad antibacteriana.

Also Published As

Publication number Publication date
TNSN03141A1 (fr) 2005-12-23
US20070014857A1 (en) 2007-01-18
PL366803A1 (en) 2005-02-07
OA12635A (fr) 2006-06-15
WO2003000225A3 (fr) 2003-03-13
HRP20031067B1 (en) 2011-10-31
ATE290366T1 (de) 2005-03-15
BG108458A (bg) 2005-02-28
BG66314B1 (bg) 2013-04-30
HK1067558A1 (en) 2005-04-15
CN1239149C (zh) 2006-02-01
CZ20033441A3 (en) 2004-03-17
EP1401397B1 (fr) 2005-03-09
PE20030201A1 (es) 2003-03-12
HRP20031067A2 (en) 2004-04-30
NZ530042A (en) 2005-09-30
UY27341A1 (es) 2003-01-31
MY134340A (en) 2007-12-31
TWI228049B (en) 2005-02-21
PT1401397E (pt) 2005-05-31
AP2003002927A0 (en) 2003-12-31
CA2452239C (fr) 2011-07-19
GT200200115A (es) 2003-02-27
FR2826274B1 (fr) 2003-09-26
SK285865B6 (sk) 2007-10-04
MA27042A1 (fr) 2004-12-20
PL202090B1 (pl) 2009-06-30
ZA200309479B (en) 2005-04-26
GT200200115AA (es) 2005-01-12
AR036096A1 (es) 2004-08-11
CZ299947B6 (cs) 2009-01-07
HUP0400799A2 (hu) 2004-08-30
ES2236574T3 (es) 2005-07-16
DE60203178D1 (de) 2005-04-14
JO2325B1 (en) 2006-06-28
HUP0400799A3 (en) 2012-08-28
JP2004534810A (ja) 2004-11-18
NO20035581D0 (no) 2003-12-15
CA2452239A1 (fr) 2003-01-03
EP1401397A2 (fr) 2004-03-31
DE60203178T2 (de) 2006-01-26
BRPI0208998A2 (pt) 2017-06-06
JP4880871B2 (ja) 2012-02-22
EA200400061A1 (ru) 2004-06-24
NO332258B1 (no) 2012-08-13
FR2826274A1 (fr) 2002-12-27
IL159404A0 (en) 2004-06-01
WO2003000225A2 (fr) 2003-01-03
US20040142029A1 (en) 2004-07-22
MXPA03011756A (es) 2004-07-01
EA006016B1 (ru) 2005-08-25
UA77960C2 (en) 2007-02-15
US7138138B2 (en) 2006-11-21
CO5540278A2 (es) 2005-07-29
AU2002329311B2 (en) 2007-02-01
IL159404A (en) 2007-08-19
CN1529585A (zh) 2004-09-15
ECSP034915A (es) 2004-02-26
SV2003001098A (es) 2003-03-18
SK15922003A3 (sk) 2004-05-04
AP1595A (en) 2006-04-12

Similar Documents

Publication Publication Date Title
PA8548301A1 (es) Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion
CL2007003331A1 (es) Metodo para tratar cancer mediante la administracion de un agente radiosensibilizante derivado de benzo[a]trinden-4,6-diona; composicion farmaceutica que comprende dicho agente.
MXPA05007643A (es) Metodo para producir una forma farmaceutica oral con desintegracion inmediata y liberacion de ingrediente activo.
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
BR0112495A (pt) Forma de dosagem, processo para a produção de uma forma de dosagem e uso da forma de dosagem
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
CR10838A (es) Derivados de 2,3-dihidroimidazol [1,2-c] quinazolina sustituidos, de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis
AR087239A2 (es) Formulaciones farmaceuticas solidas que comprenden telmisartan
DE122011100049I1 (de) Stabile pharmazeutische Losungsformulierungen fur unter Druck stehende Inhaliergerate fur die Verabreichung abgemessener Dosen.
WO2012040623A3 (en) Nanostructured gels capable of controlled release of encapsulated agents
MX2009004874A (es) Formulaciones farmaceuticas estratificadas que comprenden una capa intermediaria que se disuelve rapidamente.
PA8586201A1 (es) Nuevas formulaciones de liberacion prolongada inyectables
AR033418A1 (es) Preparado farmaceutico mucoadhesivo desintegrable para la administracion de sustancia activa en medicina veterinaria y humana
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
CL2004000899A1 (es) Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion.
DOP2002000389A (es) Metodo para fabricar una composición farmaceutica de dosis baja que tiene una distribución y potencia del fármaco uniforme
ECSP066553A (es) Formas de administración masticables, no comprimidas dosificadas individualmente.
AR034517A1 (es) Formulacion farmaceutica
IL150528A0 (en) Ibuprofen containing active agent preparation
DE60143363D1 (de) Pharmazeutische zusammensetzungen, die die immunogenität von schwach immunogenen antigenen fördern
AU2001235783A1 (en) Therapeutic compositions for pulmonary delivery
WO2008087323A8 (fr) Forme galenique pour l'administration par voie trans-muqueuse de paracetamol
CR8371A (es) Formulaciones de medicamento que contienen saborizantes con mejores propiedades farmaceuticas
PA8549401A1 (es) Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido
PE20050443A1 (es) Formulaciones farmaceuticas transdermicas